Adecatumumab (Anti-EpCAM / TROP1 / CD326)
Products
Description
Adecatumumab (Anti-EpCAM / TROP1 / CD326) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status. MW: 145.5 KD.
Specifications
| Manufacturer Cat# | A2512 |
|---|---|
| Target | CD markers |